METROPOLITAN LIFE INSURANCE CO/NY - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 112 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$121,844
-10.7%
2,812
-5.3%
0.01%
-16.7%
Q4 2023$136,439
+100.5%
2,9680.0%0.01%
+50.0%
Q3 2023$68,041
+46.8%
2,968
+5.6%
0.00%
+100.0%
Q2 2023$46,353
+32.5%
2,811
-7.4%
0.00%
+100.0%
Q1 2022$34,975
-53.5%
3,036
-59.7%
0.00%0.0%
Q4 2021$75,189
-34.5%
7,534
-14.3%
0.00%
-50.0%
Q3 2021$114,837
-52.9%
8,793
-29.4%
0.00%
-33.3%
Q2 2021$243,771
+19.2%
12,450
+29.5%
0.00%0.0%
Q1 2021$204,511
-31.9%
9,615
-4.8%
0.00%
-25.0%
Q4 2020$300,332
+37.2%
10,1020.0%0.00%0.0%
Q3 2020$218,910
-2.8%
10,1020.0%0.00%0.0%
Q2 2020$225,275
+46.5%
10,1020.0%0.00%
+33.3%
Q1 2020$153,752
-29.0%
10,102
+7.0%
0.00%
-25.0%
Q4 2019$216,674
+23.2%
9,437
+15.9%
0.00%
+33.3%
Q3 2019$175,829
+54.0%
8,144
+56.9%
0.00%
+50.0%
Q2 2019$114,202
-7.5%
5,191
+15.3%
0.00%0.0%
Q1 2019$123,400
-8.6%
4,502
-10.3%
0.00%
-33.3%
Q4 2018$134,938
+5.8%
5,020
+14.8%
0.00%
+50.0%
Q3 2018$127,560
-34.9%
4,373
-35.3%
0.00%
-33.3%
Q4 2017$196,0006,7570.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 735,000$13,112,4003.93%
NEA Management Company, LLC 2,909,956$51,913,6153.59%
Frazier Life Sciences Management, L.P. 2,164,739$38,618,9442.80%
RA Capital Management 5,516,067$98,406,6352.23%
Samsara BioCapital, LLC 345,293$6,160,0271.27%
Rock Springs Capital Management LP 1,597,123$28,492,6740.68%
Baker Brothers Advisors 6,498,267$115,929,0830.63%
HighVista Strategies LLC 35,478$632,9280.52%
Nan Fung Group Holdings Ltd 32,520$580,1570.40%
GREAT POINT PARTNERS LLC 97,544$1,740,1850.34%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders